| AKT | AKT serine/threonine kinase |
| CMS | Medical scientific committee |
| CRAF | Raf-1 proto-oncogene, serine/threonine kinase |
| DMSO | Dimethyl sulfoxide |
| EGFR | Epidermal growth factor receptor |
| ERL | Erlotinib |
| FBS | Fetal bovine serum |
| KRAS | KRAS proto-oncogene, GTPase |
| LV16 | LV16 |
| LVEV | Lentiviral empty vector |
| MAP2K1 | Mitogen-activated protein kinase kinase 1 |
| MAPK | Mitogen-activated protein kinases |
| MAPK3 | Mitogen-activated protein kinase 3 |
| MEK | Mitogen-activated protein kinase kinase |
| NSCLC | Non-small cell lung cancer |
| PI3K | Phosphoinositide 3-chinasi |
| PMSF | Phenylmethylsulphonyl fluoride |
| Pre-miRNA | miRNA precursor |
| SCR | Scrambled negative control |
| SEL | Selumetinib |
| TKIs | Tyrosine kinase inhibitors |